Emmanuel Dulac is the founder of Zealand Pharma. Backed by Van Herk Investments. Funding history, background and contact routes on StartupFundraising.com.
Emmanuel Dulac is the President and Chief Executive Officer of Zealand Pharma A/S, a Danish biotechnology company focused on peptide-based therapies. He was appointed as Zealand Pharma's CEO in April 2019, taking over leadership of the company with a late-stage pipeline. Prior to this, he was associated with other biotech ventures, including Igyxos, where he was appointed CEO in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library